NEWS.

The ERC Starting Grants are among the most highly regarded and competitive research grants for young research group leaders in Europe. This year 494 researchers across different disciplines were selected out of 3,474 proposals. 

Dr. Hannah Uckelmann is among this years awardees is for her project “EpiTransformers”, which aims to explore the epigenetic processes responsible for driving the development of leukemia. Her ERC project specifically investigates components of the nuclear export machinery that are hijacked by cancer cells to drive oncogenic gene expression programs. The ultimate goal of Dr. Uckelmanns research is to elucidate the chromatin complexes that are essential to leukemia cells and thereby improve our understanding of disease biology.